(Q34729790)

4 August 2017

1 reference

title

Chemoprevention of bladder cancer. (English)

1 reference

4 August 2017

Ashish M Kamat

1

1 reference

PubMed ID

12109342

4 August 2017

Donald L Lamm

series ordinal

2

1 reference

4 August 2017

1 February 2002

1 reference

Urologic Clinics of North America

4 August 2017

1 reference

4 August 2017

29

1 reference

4 August 2017

157-168

1 reference

4 August 2017

1

1 reference

Tigason (etretinate) in prevention of recurrence of superficial bladder tumors. A double-blind clinical trial

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Single-nutrient effects on immunologic functions. Report of a workshop sponsored by the Department of Food and Nutrition and its nutrition advisory group of the American Medical Association

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Tea consumption and risk of bladder and kidney cancers in a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

beta-Carotene: an unusual type of lipid antioxidant.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Green tea and cancer in humans: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Epidemiologic evidence for vitamin C and vitamin E in cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Cancer of the prostate: a nutritional disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Absence of promotion potential for calcium L-ascorbate, L-ascorbic dipalmitate, L-ascorbic stearate and erythorbic acid on rat urinary bladder carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

High intake of specific carotenoids and flavonoids does not reduce the risk of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

The scientific basis for regarding vitamin A and its analogues as anti-carcinogenic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Validity of short-term examination for antipromoters of bladder carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Quinolone antibiotics: a potential adjunct to intravesical chemotherapy for bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Inhibitory effects of ascorbic acid on growth of leukemic and lymphoma cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Megadose vitamins in bladder cancer: a double-blind clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Superiority of intralesional immunotherapy with Corynebacterium parvum and Allium sativum in control of murine transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Effect of urinary pH on the progression of urinary bladder tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Prognostic parameters in superficial bladder cancer: an analysis of 315 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Effects of carotenoid administration on bladder cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Dietary risk factors in human bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Fluid intake and the risk of bladder cancer in men

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Effects of vitamins C and E on N-nitroso compound formation, carcinogenesis, and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Influence of 15 retinoic acid amides on urinary bladder carcinogenesis in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Bladder-cancer incidence in relation to vegetable and fruit consumption: a prospective study of atomic-bomb survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomised phase III study performed by the EORTC GU Group. EORTC Genito-Urinary Tract Cancer Coopera

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Dietary factors in cancer of the lower urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Chemopreventive efficacy of piroxicam administered alone or in combination with lycopene and beta-carotene on the development of rat urinary bladder carcinoma after N-butyl-N-(4-hydroxybutyl)nitrosamine treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Inhibitory effect of tomato juice on rat urinary bladder carcinogenesis after N-butyl-N-(4-hydroxybutyl)nitrosamine initiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

The role of epidemiology in cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Chemoimmunoprophylaxis of an experimental bladder cancer with retinoids and Bacillus Calmette Guérin

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

The importance of selenium to human health

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Human tumour-induced inhibition of interferon action in vitro: reversal of inhibition by beta-carotene (pro-vitamin A).

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Allium sativum (garlic) treatment for murine transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Dietary factors and the incidence of cancer of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Inhibition of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rats by green tea

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Proposed uses of ascorbic acid in prevention of bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

dl-alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Vitamin A supplements, fried foods, fat and urothelial cancer. A case-referent study in Stockholm in 1985-87.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Diet and bladder cancer: a meta-analysis of six dietary variables

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Adjuvant treatment with a vitamin A analogue (etretinate) after transurethral resection of superficial bladder tumors. Final analysis of a prospective, randomized multicenter trial in Switzerland.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Pyridoxine supplementation: effect on lymphocyte responses in elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

Time course of fenretinide-induced modulation of circulating insulin-like growth factor (IGF)-i, IGF-II and IGFBP-3 in a bladder cancer chemoprevention trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

What are the critical attributes for cancer chemopreventive agents?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900022-8

7 January 2021

10.1016/S0094-0143(02)00022-8

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12109342